Artigo Acesso aberto Revisado por pares

The implementation of generics in France

2015; Volume: 4; Issue: 3 Linguagem: Inglês

10.5639/gabij.2015.0403.029

ISSN

2033-6772

Autores

Jacques Rottembourg, Jessica Nasica-Labouze,

Tópico(s)

Biotechnology and Related Fields

Resumo

The fi rst recognized and trusted generic drugs were launched in France in 1995, at the same time that the Prime Minister Alain Juppé introduced his new plan on Retirement and Social Security.It has taken 20 years for generic drugs to become integrated into the pharmacy community, and for acceptance to be reached by pharmacists, physicians and patients.The French Health Insurance Agency can potentially save close to two billion Euros per year, given its continued investment in therapeutic innovation.In the future, biosimilars will not be generics, but their market may, in years to come, play a role similar to that of the generics market.

Referência(s)